SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-031635
Filing Date
2024-03-14
Accepted
2024-03-14 17:04:49
Documents
84
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K avro-20231231.htm   iXBRL 10-K 3103394
2 EX-21.1 avro-ex21_1.htm EX-21.1 5885
3 EX-23.1 avro-ex23_1.htm EX-23.1 11768
4 EX-31.1 avro-ex31_1.htm EX-31.1 15459
5 EX-32.1 avro-ex32_1.htm EX-32.1 9784
6 EX-97.1 avro-ex97_1.htm EX-97.1 32073
  Complete submission text file 0000950170-24-031635.txt   9940324

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT avro-20231231.xsd EX-101.SCH 1337111
86 EXTRACTED XBRL INSTANCE DOCUMENT avro-20231231_htm.xml XML 1375175
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38537 | Film No.: 24751175
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)